New financing will help Moonwalk Biosciences expand its pipeline of siRNA medicines targeting adipose tissue while building out its proprietary drug discovery platform. The post Moonwalk to Use $70 Million to Develop RNAi Therapies for Obesity, Cardiometabolic Disease appeared first on GEN - Genetic Engineering and Biotechnology News .